Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J M Wit

Showing results (241-250 of 259) with videos related to

Pageof 26
Sort By:
American Journal of Diseases of Children (1960)|July 1, 1992
Growth hormone therapy in Turner's syndrome. Impact of injection frequency and initial bone ageC Rongen-Westerlaken, A van Es, J M Wit, et al.
Hormone Research|January 1, 1993
Results of long-term therapy with growth hormone in two dose regimens in Turner syndrome. Dutch Growth Hormone Working GroupH E Nienhuis, C Rongen-Westerlaken, J M Wit, et al.
Arthritis and Rheumatism|May 12, 2012
Gremlin 1, frizzled-related protein, and Dkk-1 are key regulators of human articular cartilage homeostasisJ C H Leijten, J Emons, C Sticht, et al.
European Journal of Endocrinology|August 13, 2015
The growth response to GH treatment is greater in patients with SHOX enhancer deletions compared to SHOX defectsS H Donze, C R Meijer, S G Kant, et al.
Hormone Research in Paediatrics|June 6, 2013
Pharmacokinetics and pharmacodynamics of orally administered clonidine: a model-based approachR H Klein, R Alvarez-Jimenez, R N Sukhai, et al.
European Journal of Endocrinology|January 5, 2012
A mosaic de novo duplication of 17q21-25 is associated with GH insensitivity, disturbed in vitro CD28-mediated signaling, and decreased STAT5B, PI3K, and NF-κB activationD Mul, S Wu, R A de Paus, et al.
The Journal of Clinical Endocrinology and Metabolism|July 30, 2010
Short stature associated with a novel heterozygous mutation in the insulin-like growth factor 1 geneH A van Duyvenvoorde, P A van Setten, M J E Walenkamp, et al.
Hormone Research in Paediatrics|April 30, 2014
Safety and efficacy of oxandrolone in growth hormone-treated girls with Turner syndrome: evidence from recent studies and recommendations for useT C J Sas, E J Gault, M Zeger Bardsley, et al.
Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society|January 18, 2011
The severe short stature in two siblings with a heterozygous IGF1 mutation is not caused by a dominant negative effect of the putative truncated proteinH A van Duyvenvoorde, J van Doorn, J Koenig, et al.
The Journal of Clinical Endocrinology and Metabolism|November 1, 1996
Yearly stepwise increments of the growth hormone dose results in a better growth response after four years in girls with Turner syndrome. Dutch Working Group on Growth HormoneA van Teunenbroek, S M de Muinck Keizer-Schrama, T Stijnen, et al.
Pageof 26

Showing results (241-250 of 259) with videos related to

Sort By:
Pageof 26
American Journal of Diseases of Children (1960)|July 1, 1992
Growth hormone therapy in Turner's syndrome. Impact of injection frequency and initial bone ageC Rongen-Westerlaken, A van Es, J M Wit, et al.
Hormone Research|January 1, 1993
Results of long-term therapy with growth hormone in two dose regimens in Turner syndrome. Dutch Growth Hormone Working GroupH E Nienhuis, C Rongen-Westerlaken, J M Wit, et al.
Arthritis and Rheumatism|May 12, 2012
Gremlin 1, frizzled-related protein, and Dkk-1 are key regulators of human articular cartilage homeostasisJ C H Leijten, J Emons, C Sticht, et al.
European Journal of Endocrinology|August 13, 2015
The growth response to GH treatment is greater in patients with SHOX enhancer deletions compared to SHOX defectsS H Donze, C R Meijer, S G Kant, et al.
Hormone Research in Paediatrics|June 6, 2013
Pharmacokinetics and pharmacodynamics of orally administered clonidine: a model-based approachR H Klein, R Alvarez-Jimenez, R N Sukhai, et al.
European Journal of Endocrinology|January 5, 2012
A mosaic de novo duplication of 17q21-25 is associated with GH insensitivity, disturbed in vitro CD28-mediated signaling, and decreased STAT5B, PI3K, and NF-κB activationD Mul, S Wu, R A de Paus, et al.
The Journal of Clinical Endocrinology and Metabolism|July 30, 2010
Short stature associated with a novel heterozygous mutation in the insulin-like growth factor 1 geneH A van Duyvenvoorde, P A van Setten, M J E Walenkamp, et al.
Hormone Research in Paediatrics|April 30, 2014
Safety and efficacy of oxandrolone in growth hormone-treated girls with Turner syndrome: evidence from recent studies and recommendations for useT C J Sas, E J Gault, M Zeger Bardsley, et al.
Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society|January 18, 2011
The severe short stature in two siblings with a heterozygous IGF1 mutation is not caused by a dominant negative effect of the putative truncated proteinH A van Duyvenvoorde, J van Doorn, J Koenig, et al.
The Journal of Clinical Endocrinology and Metabolism|November 1, 1996
Yearly stepwise increments of the growth hormone dose results in a better growth response after four years in girls with Turner syndrome. Dutch Working Group on Growth HormoneA van Teunenbroek, S M de Muinck Keizer-Schrama, T Stijnen, et al.
Pageof 26